Skip over main navigation
  • Log in
  • Basket: (0 items)
Hepatitis Australia
Listen
  • Search
  • Instagram
  • Twitter
  • Facebook
  • YouTube
Info line  Donate
Menu
  • About us
    • Who we are
    • Our Team
    • Our Board
    • Our Members
    • Corporate documents
    • Our website
    • Contacting Us
  • Hepatitis information
    • Liver Health
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Other Languages
  • How to get help
    • COVID-19
    • Hepatitis Infoline
    • Your Rights and Responsibilities
    • For friends and family
    • Local hepatitis organisations
  • Get involved
    • Donate
    • Stories
  • Our work
    • World Hepatitis Day
    • Ending Hepatitis C Campaign
    • National Hep C 50,000 Project
    • Policy and Advocacy
    • Our publications
    • Past campaigns
  • News
    • Latest News
    • Media Releases
  • Workforce
    • Community
    • Professionals
    • Training Opportunities
  • Admin
    • Log in
  • Basket: (0 items)
  1. News
  2. Media Releases

Media Releases

Below is a series of media releases and media statements from Hepatitis Australia.

Media outlets wishing to arrange interviews should contact our office on 02 6232 4257 or send an email.

The latest data relating to hepatitis B or C is available on our Hepatitis Statistics page.

World Hepatitis Summit 2022 urges action to eliminate viral hepatitis as every 30 seconds a person dies from a hepatitis-related illness

World Hepatitis Summit 2022 urges action to eliminate viral hepatitis as every 30 seconds a person dies from a hepatitis-related illness

The World Hepatitis Summit 2022 will review progress and renew commitments by global partners to accelerate action to achieve the global target of eliminating of viral hepatitis by 2030. Read more

Published: 7th June, 2022

Author: Hepatitis Australia

12 month funding a lifeline but 2030 hepatitis elimination goals demand longer-term investment

12 month funding a lifeline but 2030 hepatitis elimination goals demand longer-term investment

Hepatitis Australia welcomes the Australian Government’s commitment of short-term (12 months) funding under the National Preventive Health Strategy 2021-2030 to support key organisations to continue existing programs in the national response to hepatitis B, hepatitis C, HIV and STIs. Read more

Published: 29th March, 2022

Author: Danny Adams

Removing barriers to telehealth will improve access to hepatitis B treatment and hepatitis C cures

Removing barriers to telehealth will improve access to hepatitis B treatment and hepatitis C cures

Media Statement Budget 2021: Hepatitis Australia welcomes the Australian Government’s commitment to extend telehealth and remove access barriers in the 2021 Budget. Patients with hepatitis B and hepatitis C can now access treatment via telehealth without needing to have previously or recently seen that clinician. Read more

Published: 12th May, 2021

Author: Grace Hogan

Investment in life saving research can eliminate viral hepatitis

Investment in life saving research can eliminate viral hepatitis

Media statement Budget 2021: Hepatitis Australia welcomes the Australian Government’s significant investment of $6.7 billion in medical research over the next 4 years, including $2.6 billion for the Medical Research Future Fund (MRFF) and $3.6 billion for the National Health and Medical Research Council (NHMRC). Read more

Published: 12th May, 2021

Author: Grace Hogan

Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

The Australian Injecting and Illicit Drug Users League (AIVL) and Hepatitis Australia are highlighting international calls for Needle and Syringe Programs (NSPs) in prisons, along with a greater focus on harm reduction initiatives, ahead of International Drug Users Day on 1 November. Read more

Published: 29th October, 2020

Updated: 30th October, 2020

Author: Grace Hogan

Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

6 October 2020 - Hepatitis Australia welcomes the Australian Government’s commitment to diverse hepatitis research, however we remain concerned that the 2019 Health Budget funding for hepatitis commitments is yet to hit the ground. Read more

Published: 6th October, 2020

Updated: 7th October, 2020

Author: Grace Hogan

Investment in liver cancer medicines matched with prevention are changing Australian lives

Investment in liver cancer medicines matched with prevention are changing Australian lives

6 October 2020 - Hepatitis Australia welcomes the Australian Government’s significant investment of $230 million to expand the listing of Tecentriq® and Avastin® (atezolizumab and bevacizumab) on the Pharmaceutical Benefits Scheme (PBS). Read more

Published: 6th October, 2020

Updated: 7th October, 2020

Author: Grace Hogan

2020 Nobel Prize awarded for discovery of hepatitis C virus

2020 Nobel Prize awarded for discovery of hepatitis C virus

6 October 2020 - Hepatitis Australia is celebrating the news that the Nobel Prize in Physiology or Medicine 2020 has been awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice ‘for the discovery of Hepatitis C virus’. Read more

Published: 6th October, 2020

Updated: 7th October, 2020

Author: Grace Hogan

Let’s Talk Hep on World Hepatitis Day – 28 July

Let’s Talk Hep on World Hepatitis Day – 28 July

As Australia grapples with COVID-19 outbreaks, it is important to remember that viral hepatitis is also a pandemic. Viral hepatitis can lead to liver cancer and directly impacts nearly 360,000 people in Australia. Read more

Published: 28th July, 2020

Updated: 20th August, 2020

Author: Kevin Marriott

Hepatitis Australia appoints new CEO

Hepatitis Australia appoints new CEO

04 March 2020 - Hepatitis Australia announces appointment of new CEO Read more

Published: 4th March, 2020

Author: Kevin Marriott

New President to lead the Board of Hepatitis Australia

New President to lead the Board of Hepatitis Australia

17 January 2020 - Hepatitis Australia announces Grant Phelps as the new President of the Board. Read more

Published: 16th January, 2020

Author: Kevin Marriott

Welcome to our new website

Welcome to our new website

Welcome to our newly updated website. The fresh new look is easier to navigate, so finding information about hepatitis or how to get help is even simpler.  Read about the new features and how to leave feedback here. Read more

Published: 25th June, 2019

Author: Grace Hogan

New hepatitis C treatment data confirms time for action is now

New hepatitis C treatment data confirms time for action is now

The latest hepatitis C treatment data released by the Kirby Institute shows that, since March 2016, an estimated 70,260 people in Australia have commenced treatment to cure hepatitis C*. But is this enough to prevent the ongoing deaths each year in Australia from liver disease associated with hepatitis? Read more

Published: 20th June, 2019

Author: Kevin Marriott

No cause for celebration yet - more to do to stop hepatitis C deaths

No cause for celebration yet - more to do to stop hepatitis C deaths

In England deaths from liver disease related to hepatitis C fell by more than 16% between 2015 and 2017, achieving the World Health Organization’s (WHO’s) target to reduce HCV-related mortality by 10% by 2020 three years early. Australia has also achieved the WHO’s 2020 mortality target. Some might say that this is good news - but at Hepatitis Australia we don’t agree. Read more

Published: 2nd May, 2019

Updated: 5th June, 2019

Author: Kevin Marriott

Hepatitis Australia welcomes The Australian Greens commitment to viral hepatitis helping to end liver cancer deaths.

Hepatitis Australia welcomes The Australian Greens commitment to viral hepatitis helping to end liver cancer deaths.

Hepatitis Australia is pleased to have received full support from The Australian Greens for our call to address gaps in hepatitis treatment and care. Read more

Published: 30th April, 2019

Updated: 7th June, 2019

Author: Kevin Marriott

Back to top

Showing 10 of 15

Latest

  • Ending Hepatitis C Campaign

    Ending Hepatitis C Campaign

    Working with communities to end hepatitis C in Australia

  • World Hepatitis Day 2022

    World Hepatitis Day 2022

    World Hepatitis Day is an opportunity to step up national and international efforts on hepatitis.

  • World Hepatitis Summit 2022 urges action to eliminate viral hepatitis as every 30 seconds a person dies from a hepatitis-related illness

    World Hepatitis Summit 2022 urges action to eliminate viral hepatitis as every 30 seconds a person dies from a hepatitis-related illness

    The World Hepatitis Summit 2022 will review progress and renew commitments by global partners to accelerate action to achieve the global target of eliminating of viral hepatitis by 2030.

  • Hepatitis Australia welcomes new Australian Government

    Hepatitis Australia welcomes new Australian Government

    Hepatitis Australia looks forward to working with the new Australian Government to eliminate hepatitis B and hepatitis C.

Most read

  • A cure for hepatitis C

    A cure for hepatitis C

    Highly effective medicines are available in Australia to cure hepatitis C

  • No, you’re not being tested for hepatitis as part of a routine blood test

    No, you’re not being tested for hepatitis as part of a routine blood test

    Hepatitis B and C are the most common blood borne viruses in Australia but testing for them is not part of normal blood tests—you generally have to ask your doctor.

  • Living with hepatitis B: The myth of the healthy carrier

    Living with hepatitis B: The myth of the healthy carrier

    If you’ve been told that you are “just a healthy carrier”, read on for a myth-busting update from Dr Alice Lam.

  • What is hepatitis C?

    What is hepatitis C?

    Basic information about hepatitis C and how it can affect you.

  • Hepatitis B treatment

    Hepatitis B treatment

    Who needs treatment for hepatitis B and what is involved.

  • Testing for hepatitis B

    Testing for hepatitis B

    Tests used to diagnose hepatitis B

  • Hepatitis B vaccination

    Hepatitis B vaccination

    Hepatitis B can be prevented with a safe and effective vaccine.

  • Testing for hepatitis C

    Testing for hepatitis C

    Information about the tests used to diagnose hepatitis C (hep C) infection

  • What is hepatitis B?

    What is hepatitis B?

    Basic information about hepatitis B transmission and how it affects people.

  • Hepatitis C symptoms

    Hepatitis C symptoms

    Symptoms of hepatitis C are not always obvious

Info

Hepatitis Australia is a registered charity. 
ABN: 38 442 686 487

© Copyright 2019 Hepatitis Australia.
All rights reserved.
View our copyright statement here

Helpful links

  • Contact us
  • Full sitemap
  • Accessibillity
  • Terms & conditions
  • Privacy policy
  • Login
  • Logout
  • Manager

Member sites

  • Australian Capital Territory
  • New South Wales
  • Northern Territory
  • South Australia
  • Victoria
  • Queensland
  • Western Australia
  • Tasmania 

Information provided on this website is for general information only and not intended as medical advice. Hepatitis Australia encourages all readers to seek independent medical advice before making any decisions based on the information provided on this website.

Hepatitis Australia is a partner organisation of healthdirect Australia.
healthdirect - trusted health advice

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information: verify here.
Search only trustworthy HONcode health websites: 

Images used on this site may include stock photos and the associated messaging may not represent the personal situation, views or beliefs of the people in the images.